The result of decades of innovation and experience in the field of pharmaceutical testing, the DTGi Series of disintegration testers from Copley simplifies testing within R&D and QC environments. Suitable for a wide range of tablet and capsule types (e.g. plain-coated tablets, delayed-release, gelatine etc.), the DTGi tester series is an affordable range of disintegration testers that complies fully with specifications defined in Ph. Eur., USP and associated Pharmacopoeias.
Controlled via our intuitive touchscreen interface, the DTGi 100i is a single station disintegration tester. The user-friendly design makes assessing disintegration characteristics a simple touch-of-a-button task.
Pharmacopoeial Compliance:
Ph. Eur. 2.9.1
USP and
Number of Test Stations:
1
Tablet Capacity:
Up to 6
Independent Station Control:
No
Unit Dimensions (w x d x h):
450 x 473 x 657 mm
Key DTGi Series Highlights
Ph. Eur. and USP and compliant
Integrated, precision temperature control and measurement
Single-point electronic temperature calibration
Intuitive touchscreen control to simplify operation
One to four test station unit configurations, plus independent station control unit option
Extensive data reporting output options: RS 232, USB A and USB B
Adjustable stroke frequency control for accelerated or high sensitivity testing
Option to automate and remotely control DTGi systems
DTGi Compliance & Maintenance
Certificate of compliance to Ph. Eur./USP provided as standard
Comprehensive IQ/OQ/PQ documentation packages and toolkits available
Passcode-protected single-point electronic temperature calibration